Cargando…
MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment
SIMPLE SUMMARY: Based on the latest research progresses, application of immune checkpoint inhibitors (ICIs) has shown promise in treating breast cancer. Moreover, novel ICIs based combined therapy has been sought to further enhance the curative effect. This review brings up a whole new conception of...
Autores principales: | Zhou, Huiling, Jia, Wentao, Lu, Lingeng, Han, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913694/ https://www.ncbi.nlm.nih.gov/pubmed/36765782 http://dx.doi.org/10.3390/cancers15030824 |
Ejemplares similares
-
CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment
por: Han, Rui, et al.
Publicado: (2023) -
MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors
por: Motti, Maria Letizia, et al.
Publicado: (2020) -
Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules
por: Alotaibi, Faizah
Publicado: (2023) -
Immune checkpoint inhibitors
por: Hui, Enfu
Publicado: (2019) -
Immune checkpoint inhibitors
por: Kroemer, Guido, et al.
Publicado: (2021)